Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure.

Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure.

Modulation of the immune system may be a viable alternative in the treatment of fulminant hepatic failure (FHF) and can potentially eliminate the need for donor hepatocytes for cellular therapies. Multipotent bone marrow-derived mesenchymal stem cells (MSCs) have been shown to inhibit the function o...

Full description

Bibliographic Details
Main Authors: Biju Parekkadan, Daan van Poll, Kazuhiro Suganuma, Edward A Carter, François Berthiaume, Arno W Tilles, Martin L Yarmush
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2007-09-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC1978513?pdf=render

Internet

http://europepmc.org/articles/PMC1978513?pdf=render

Similar Items